 random comparison ceftriaxon cefotaxim lyme neuroborreliosi prospect open trial patient lyme neuroborreliosi treatment ceftriaxon iv cefotaxim iv patient elig analysi therapeut efficaci neurolog patient cefotaxim group patient ceftriaxon group treatment period follow-up examin mean month patient asymptomat patient borrelia burgdorferi cerebrospin fluid csf month ceftriaxon therapi csf antibiot concentr mic level burgdorferi patient patient lyme neuroborreliosi treatment ceftriaxon cefotaxim patient symptomat follow-up borrelia csf patient prolong therapi necessari